February 2024 - Volume 46 - Issue 1（2024年2月第46卷第1期）
https://journals.lww.com/drug-monitoring/pages/currenttoc.aspx

Review Article（综述文章）
        1. Pharmacobezoar相关死亡：一份病例报告和文献综述
        (Pharmacobezoar-Related Fatalities: A Case Report and a Review of the Literatures)
        作者：Guillaume Drevin* (Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire, France)

        2. 基于质谱的依从性监测的样本矩阵：一份系统批判性评价
        (Sample Matrices for Mass Spectrometry–Based Adherence Monitoring: A Systematic Critical Review)
        作者：Jacobs, Cathy M, Wagmann, Lea*(Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Germany)

         3. 正电子发射断层扫描成像的最新经验教训（I）：抗精神病药物治疗性血浆浓度的系统批判性综述
        (Update Lessons from Positron Emission Tomography Imaging Part I: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antipsychotics)
        作者：Hart, Xenia M* (Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Germany)

        4. 五酯胶囊对他克莫司全血浓度的影响：系统评价和Meta分析
        (Effects of Wuzhi Capsule on Whole-Blood Tacrolimus Concentration Levels: A Systematic Review and Meta-Analysis)
        作者：Zhang, Chunyan, Huang, Lin*, Zhang, Xiaohong* (Department of Pharmacy, Peking University People's Hospital, China)

        Original Article（原创文章）
        1. 治疗范围内他克莫司使用时间对肝癌肝移植患者术后复发的影响
        (Effect of Tacrolimus Time in Therapeutic Range on Postoperative Recurrence in Patients Undergoing Liver Transplantation for Liver Cancer)
        作者：Lao, Qianying, Zhu, Huaijun* (Department of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, China)

        2. 应用高效 LC-MS/MS 测定肾移植受者血浆他克莫司浓度
        (Determining Plasma Tacrolimus Concentrations Using High-Performance LC-MS/MS in Renal Transplant Recipients)
        作者：Alonge, Mirabel BHlthMSc(Hons), Benedetta C* (Department of Clinical Pharmacology, The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Australia)

        3. 通过群体药代动力学模型预测突尼斯成人肾移植后他克莫司的个体化起始剂量
        (A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus for Tunisian Adults after Renal Transplantation)
        作者：Abderahmene, Amani* (Department of Biochemistry, LR12SP11, Sahloul University Hospital, Sousse, University of Monastir Faculty of Pharmacy of Monastir, Tunisia)

        4. 监测儿科患者血浆中巴瑞替尼的一种新型LC-MS/MS方法
        (A Novel LC-MS/MS Method for Therapeutic Drug Monitoring of Baricitinib in Plasma of Pediatric Patients)
        作者：Cafaro, Alessia, Barco, Sebastiano*(Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini)

        5. 激酶抑制剂克唑替尼、阿来替尼、奥希替尼、达拉非尼和曲美替尼高血浆谷水平在 NSCLC 患者中的临床意义
        (Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients)
        作者：Lin, Lishi, Alwin D. R* (Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, The Netherlands)

        6. 头孢吡肟治疗淋巴瘤或多发性骨髓瘤发热性中性粒细胞减少症的剂量个体化：对治疗药物监测的意义
        (Dose Individualization of Cefepime for Febrile Neutropenia in Patients With Lymphoma or Multiple Myeloma: Implications for Therapeutic Drug Monitoring)
        作者：Oda, Kazutaka* (Infection Control, Kumamoto University Hospital, Japan)

        7. 晚期肝病患者使用伏立康唑的治疗药物监测
        (Therapeutic Drug Monitoring of Voriconazole in Patients with End-Stage Liver Disease)
        作者：Wu, Zhenyu, Zhang, Min* (Department of Infectious Diseases, The Second Xiangya Hospital of Central South University, China)

        8. 贝叶斯引导的 β-内酰胺输注策略以及在重症肺炎患者中的相关细菌耐药性和临床结果的随机临床试验    
        (A Randomized Clinical Trial of Bayesian-Guided Beta-Lactam Infusion Strategy and Associated Bacterial Resistance and Clinical Outcomes in Patients With Severe Pneumonia)
        作者：Maranchick, Nicole F* (Infectious Disease Pharmacokinetics Lab, Emerging Pathogens Institute, University of Florida, USA)

        9. 使用头发和尿液分析评估医院专业人员的内分泌干扰物暴露：一项提高认知的活动
        (Assessment of Endocrine Disruptor Exposure in Hospital Professionals Using Hair and Urine Analyses: An Awareness Campaign)
        作者：Robin, Julien, Venisse, Nicolas* (Biology-Pharmacy-Public Health Department, University Hospital of Poitiers, France)

        10. 吡仑帕奈在中国儿童癫痫患者中的血浆浓度、疗效和耐受性：真实世界的临床经验
        (Plasma Concentration, Efficacy, and Tolerability of Perampanel in Chinese Pediatric Patients with Epilepsy: Real-World Clinical Experience)
        作者：Zhao, Ting, Sun, Yan* (Department of Neurology, Children's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hospital of Beijing Children's Hospital, China)

         11. 应用LC-MS/MS分析滥用药物尿液标记物的基质效应
        (Matrix Effects of Urine Marker Substances in LC-MS/MS Analysis of Drug of Abuse)
        作者：Huppertz, Bernd* (MVZ Labor Dr. Quade & Kollegen, Germany)

         Short Communication（短通信）
        1. 维奈克拉在急性髓系白血病患者中的药代动力学研究：TDM的潜在候选者？一份简短的交流
        (Pharmacokinetic Consideration of Venetoclax in Acute Myeloid Leukemia Patients: A Potential Candidate for TDM? A Short Communication)
        作者：Philippe, Michael* (Department of Pharmacy, Centre Leon Berard, France)